Qinwangchuan biopharmaceutical production area will be built – china medical cru
According to “Lanzhou Daily” reported that an area of approximately 2,000 acres of bio-pharmaceutical production areas, is expected to Yongdeng Qinwangchuan circular economy garden home to the airport and surrounding areas of radiation medicine promote standardization of cultivation. Reporter yesterday from Lanzhou, the Office of Bio-medical technology industry, understand that the city is planning biological and medical technology industry base, the proposed YU Qin Wang Chuan is a bio-pharmaceutical production areas, the planning is one of the three major functional areas.
R & D efforts focus on Lanzhou
According to reports, Lanzhou advantages of bio-pharmaceutical industry is extremely obvious that 70% of the province’s bio-pharmaceutical industry research and development efforts concentrated on these. There Lanzhou, Lanzhou Branch of Chinese Academy of Sciences and other 11 with the authority of the relevant biomedical research and development institutions in the country affecting more than 40 patents; has more than 30 major bio-pharmaceutical enterprises, production and product variety more than a thousand months. Meanwhile, the province is the main origin of Chinese herbal medicines, one of the country, the main resources for 1527 kinds of Chinese herbal medicines, in order to Lanzhou, the development of bio-medicine industry provides a rich resource base.
Yet the formation of industrial advantages
It can be said in the bio-pharmaceutical industry in Lanzhou, the basis of very good, there are talented people, technology, with equipment, but not the formation of industrial advantages. In addition to Chengguan District yanchangbu history of the region focused on the formation of bio-medicine outside the region, there is no production and research the integration of biomedical industry park is not conducive to R & D of new drugs and to attract high-level professionals; and, Lanzhou, small-scale bio-pharmaceutical industry as a whole, the lack of year more than 1 billion yuan output value of large-scale backbone enterprises and leading large variety of more than 100 million yuan annual sales driven, project lack of funds, production and lack of space, lack of R & D investment, marketing, lack of ability, talent shortage led the development of the more prominent issues such as lack of conditions; long-term Since the bio-pharmaceutical industry fragmentation, Lanzhou, free development, information poor, waste of resources, lack of strong government co-ordination and policy guidance.
Development thinking has been formed
Lanzhou biomedical industry for the current situation and development potential, in the reported cases pending in this plan, put forward the city’s biomedical technology industry base in the development of the “538” line of thought. Namely, the development “5 major areas”, including bio-products, Chinese and Tibetan medicine, chemicals, heavy ion beam biological applications and biomedical materials. Building “three functional areas”, that is yanchangbu community building the core area of biomedical research, because this place brings together eight biomedical R & D enterprise, focused on bio-pharmaceutical enterprises in Lanzhou more than 60% of the fixed assets and more than 80% of the industrial GDP; has Yongdeng county circular economy coordination to Airport Park, 2000 acres of land for the construction of bio-pharmaceutical production areas. Separation of Lanzhou 272 million investment in scientific research in the area where the construction of peptide Series Comprehensive raw material drug production project has been officially put to production; Lanzhou Bio-Pharmaceutical Co., Ltd. will also benefit Investment 3 billion on the construction of drug production project.
In addition, the construction of biological products will be displayed to. Into a “8 Center,” relying on Separation Science, Lanzhou Institute of Construction “Lanzhou biochemical engineering technology center”; relying Lanzhou, Lanzhou Institute of Biological Products and Veterinary Institute, building “Lanzhou Biological Engineering Technology Research and Development Center”; relying Lanzhou Foci Pharmaceutical Co., Ltd. and Gansu qi are Industrial Group Co., Ltd., building “Modernization of Chinese Medicine, Lanzhou Engineering Technology Research and Development Center”; relying on the construction of Lanzhou University, “Experimental Center, Lanzhou GLP”; government investment as the mainstay, supplemented by business investment, construction ” Lanzhou bio-pharmaceutical industry information service center “.
I am an expert from chinacervicalcollar.com, while we provides the quality product, such as china medical crutch , finger splint, cervical collar,and more.
Processing your request, Please wait....
